Articles

An economic evaluation study assesses these costs by therapeutic class, while identifying trends in pharma R&D intensity over time. 

Determining Drug Development Costs in the United States

Expansion of these offerings will occur at the company’s 60,000 square-foot Lincolnshire Center of Excellence

SGS North America Strengthens Its Biologics Testing Services

Double-digit, year-on-year growth is now on a six-month streak.

Air Freight Demand Continues for May

An observational, retrospective cohort study undergoes this investigation in individuals 24 years of age or older. 

Comparing Bariatric Metabolic Surgery, Glucagon-Like Peptide-1 Receptor Agonists Mortality Among Patients with Obesity and Diabetes 

The investment is expected to help enhance the company temperature-controlled services in the Netherlands, France, Italy, and Hungary.

UPS Healthcare Financially Commits Over $21.6 Million Toward Cold Chain Fleet

The Stelara biosimilar will be commercialized by Sandoz, and is expected to launch by February 2025 for multiple indications, including for the treatment of adult patients with active psoriatic arthritis.

FDA Approves Pyzchiva for Use in the United States

The deal provides the CDMO with ownership of the Lexington facility, allowing for late-phase and commercial gene therapy development and manufacturing of a branded severe Hemophilia B product. 

 Genezen Purchases uniQure’s Gene Therapy Operations in Massachusetts

A cross-sectional study evaluates the difference in clinical outcomes and demographics between pediatric RSV patients during these multiple timeframes. 

Analyzing the Effects of Respiratory Syncytial Virus Pre- and Post-Pandemic

The CRDMO will contribute cell discovery services that will benefit clinical development of novel technologies.

Aurigene, Edity Introduce Cell Therapy Collaboration

Following the evaluation, the company will decide whether it wants to move forward with the IDMO’s automated, end-to-end, cell therapy manufacturing platform. 

News